No this is insane news, the world is crazy and dumb. Must be all these LLMs. Stock up more than 150%, based on totally unpublished data and an X post...
- The flashy 49% figures are from the old 157 only patient Phase 2, not this Phase 3 trial. The phase 2 was open label, had only 50 controls, and its randomization was disrupted. Meaning 9 patients were reassigned and the final 37 were no longer randomized. Its primary RFS result was p=0.053 two-sided, with the 95% CI crossing 1. It also used an unusually permissive one-sided alpha of 0.10, and much of the later "confirmation" is just longer follow up of those same 157 patients...
- This phase 3 news so far is nothing more than a press release. They have not published hazard ratio, or confidence interval, their event counts or survival curves.
- They met the endpoint as used in the press release means nothing, until they publish the actual 3 data, so my money is at the end this will be a kind of marginal effect that researchers will struggle to reproduce for years
Another type of study that will take 2 to 3 years to validate or dismiss, in the meanwhile stock is up 150%....